BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38200678)

  • 21. Predictors of advanced colorectal neoplasia for colorectal cancer screening.
    Wong MC; Lam TY; Tsoi KK; Chan VC; Hirai HW; Ching JY; Sung JJ
    Am J Prev Med; 2014 May; 46(5):433-9. PubMed ID: 24745632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrence rates of advanced colorectal neoplasia (ACN) in subjects with baseline ACN followed up at different surveillance intervals.
    Wong MCS; Leung EY; Chun SCC; Deng Y; Lam T; Tang RSY; Huang J
    Dig Liver Dis; 2023 Dec; 55(12):1742-1749. PubMed ID: 37127494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of adenomatous polyposis in a fecal immunochemical test-based colorectal cancer screening program and risk of advanced neoplasia during follow-up.
    Carballal S; Sánchez A; Moreira L; Cuellar-Monterrubio JE; Bernuy J; Daca M; Ortiz O; Ocaña T; Rivero-Sánchez L; Jung G; Serradesanferm A; Pozo A; Grau J; Torá I; Zaffalon D; Castells A; Pellisé M; Balaguer F;
    Endoscopy; 2022 Jul; 54(7):688-697. PubMed ID: 34607378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of subsequent screening episodes on the positive predictive value for advanced neoplasia and on the distribution of anatomic subsites of colorectal cancer: A population-based study on behalf of the French colorectal cancer screening program.
    Azimafoussé Assogba GF; Jezewski-Serra D; Lastier D; Quintin C; Denis B; Beltzer N; Duport N
    Cancer Epidemiol; 2015 Dec; 39(6):964-71. PubMed ID: 26546750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Compliance rate of screening colonoscopy and its associated factors among high-risk populations of colorectal cancer in urban China].
    Chen HD; Li N; Ren JS; Shi JF; Zhang YM; Zou SM; Zheng ZX; Zhang K; Dai M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):231-237. PubMed ID: 29973000
    [No Abstract]   [Full Text] [Related]  

  • 26. Validity of APCS score as a risk prediction score for advanced colorectal neoplasia in Chinese asymptomatic subjects: A prospective colonoscopy study.
    Li W; Zhang L; Hao J; Wu Y; Lu D; Zhao H; Wang Z; Xu T; Yang H; Qian J; Li J
    Medicine (Baltimore); 2016 Oct; 95(41):e5123. PubMed ID: 27741134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Findings in the distal colorectum are not associated with proximal advanced serrated lesions.
    Kahi CJ; Vemulapalli KC; Snover DC; Abdel Jawad KH; Cummings OW; Rex DK
    Clin Gastroenterol Hepatol; 2015 Feb; 13(2):345-51. PubMed ID: 25083562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early-Age Onset Colorectal Neoplasia in Average-Risk Individuals Undergoing Screening Colonoscopy: A Systematic Review and Meta-Analysis.
    Kolb JM; Hu J; DeSanto K; Gao D; Singh S; Imperiale T; Lieberman DA; Boland CR; Patel SG
    Gastroenterology; 2021 Oct; 161(4):1145-1155.e12. PubMed ID: 34119517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study.
    Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S
    Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Esophagogastroscopic Abnormalities Potentially Guided Patients Younger than 50 Years Old to Undergo Colonoscopy Earlier: A Retrospective Cross-Sectional Study.
    Han Z; Guo X; Peng C; Zhang W; Nan X; Wan M; Li Y; Li Y
    Dig Dis Sci; 2024 Jan; 69(1):36-44. PubMed ID: 37989896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Derivation and validation of a risk scoring model to predict advanced colorectal neoplasm in adults of all ages.
    Yang HJ; Choi S; Park SK; Jung YS; Choi KY; Park T; Kim JY; Park DI
    J Gastroenterol Hepatol; 2017 Jul; 32(7):1328-1335. PubMed ID: 28012211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A sex-specific propensity-adjusted analysis of colonic adenoma detection rates in a screening cohort.
    Wernly S; Wernly B; Semmler G; Bachmayer S; Niederseer D; Stickel F; Huber-Schönauer U; Aigner E; Datz C
    Sci Rep; 2021 Sep; 11(1):17785. PubMed ID: 34493755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test-Based Screening for Colorectal Cancer.
    Duran-Sanchon S; Moreno L; Gómez-Matas J; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Serradesanferm A; Pozo À; Grau J; Pellisé M; Gironella M; Castells A
    Clin Gastroenterol Hepatol; 2021 Feb; 19(2):323-330.e1. PubMed ID: 32113893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of Advanced Neoplasia Using the National Cancer Institute's Colorectal Cancer Risk Assessment Tool.
    Imperiale TF; Yu M; Monahan PO; Stump TE; Tabbey R; Glowinski E; Ransohoff DF
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27582444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and Predictors of Young-Onset Colorectal Neoplasia: Insights From a Nationally Representative Colonoscopy Registry.
    Trivedi PD; Mohapatra A; Morris MK; Thorne SA; Smith SC; Ward AM; Schroy P; Hampel H; Jandorf L; Popp JW; Itzkowitz SH
    Gastroenterology; 2022 Apr; 162(4):1136-1146.e5. PubMed ID: 35007513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study).
    González-López N; Quintero E; Gimeno-Garcia AZ; Bujanda L; Banales J; Cubiella J; Salve-Bouzo M; Herrero-Rivas JM; Cid-Delgado E; Alvarez-Sanchez V; Ledo-Rodríguez A; de-Castro-Parga ML; Fernández-Poceiro R; Sanromán-Álvarez L; Santiago-Garcia J; Herreros-de-Tejada A; Ocaña-Bombardo T; Balaguer F; Rodríguez-Soler M; Jover R; Ponce M; Alvarez-Urturi C; Bessa X; Roncales MP; Sopeña F; Lanas A; Nicolás-Pérez D; Adrián-de-Ganzo Z; Carrillo-Palau M; González-Dávila E;
    PLoS Med; 2023 Oct; 20(10):e1004298. PubMed ID: 37874831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One-Time Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD (DETECT Study).
    Wong G; Hope RL; Howard K; Chapman JR; Castells A; Roger SD; Bourke MJ; Macaskill P; Turner R; Williams G; Lim WH; Lok CE; Diekmann F; Cross NB; Sen S; Allen RDM; Chadban SJ; Pollock CA; Tong A; Teixeira-Pinto A; Yang JYH; Williams N; Au EHK; Kieu A; James L; Craig JC
    J Am Soc Nephrol; 2019 Jun; 30(6):1061-1072. PubMed ID: 31040191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer.
    Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam ME; Dekker E; van Ballegooijen M; Kuipers EJ; Fockens P; Kraaijenhagen RA; Bossuyt PM
    Cancer Epidemiol; 2013 Jun; 37(3):278-83. PubMed ID: 23491770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postponing colonoscopy for 6 months in high-risk population increases colorectal cancer detection in China.
    Zhang M; Zhang Y; Zhang W; Zhao L; Jing H; Wu X; Guo L; Zhang H; Zhang Y; Zhu S; Zhang S; Zhang X
    Cancer Med; 2023 May; 12(10):11816-11827. PubMed ID: 36951442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
    Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.